Clinical Trial Update: Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating losartan in patients with nonobstructive hypertrophic cardiomyopathy, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hypertrophic Cardiomyopathy | Phase 2 | Status: COMPLETED | Results posted: 2013-09-05